Literature DB >> 28398593

CCR5 expression, haplotype and immune activation in protection from infection in HIV-exposed uninfected individuals in HIV-serodiscordant relationships.

Shameem Z Jaumdally1,2, Anabela Picton3,4, Caroline T Tiemessen3,4, Maria Paximadis3,4, Heather B Jaspan1, Hoyam Gamieldien1, Lindi Masson1,2, David Coetzee5, Anna-Lise Williamson1,6, Francesca Little7, Pamela P Gumbi1,2, Jo-Ann S Passmore1,2,6.   

Abstract

Several host factors have been implicated in resistance to HIV infection in individuals who remain HIV-seronegative despite exposure. In a cohort of HIV-serodiscordant heterosexual couples, we investigated interactions between systemic inflammation and T-cell activation in resistance to HIV infection. Males and females in stable long-term relationships with either HIV-infected or uninfected partners were recruited, blood T-cell activation (CD38, HLA-DR, CCR5 and Ki67) and plasma cytokine concentrations were evaluated. The HIV-negative exposed individuals had significantly lower frequencies of CCR5+ CD4+ and CD8+ T cells than unexposed individuals. Mean fluorescence intensity of CCR5 expression on CD4+ T cells was significantly lower in HIV-negative exposed than unexposed individuals. Protective CCR5 haplotypes (HHA/HHF*2, HHF*2/HHF*2, HHC/HHF*2, HHA/HHA, HHA/HHC and HHA/HHD) tended to be over-represented in exposed compared with unexposed individuals (38% versus 28%, P = 0·58) whereas deleterious genotypes (HHC/HHD, HHC/HHE, HHD/HHE, HHD/HHD and HHE/HHE) were under-represented (26% versus 44%; P = 0·16). Plasma concentrations of interleukin-2 (P = 0·02), interferon-γ (P = 0·05) and granulocyte-macrophage colony-stimulating factor (P = 0·006) were lower in exposed compared with unexposed individuals. Activation marker expression and systemic cytokine concentrations were not influenced by gender. We conclude that the dominant signature of resistance to HIV infection in this cohort of exposed but uninfected individuals was lower T-cell CCR5 expression and plasma cytokine concentrations.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  CCR5; HIV; immune activation; resistance

Mesh:

Substances:

Year:  2017        PMID: 28398593      PMCID: PMC5506425          DOI: 10.1111/imm.12743

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  51 in total

1.  Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa.

Authors:  Craig R Cohen; Anna-Barbara Moscicki; Mark E Scott; Yifei Ma; Stephen Shiboski; Elizabeth Bukusi; Ibrahim Daud; Anu Rebbapragada; Joelle Brown; Rupert Kaul
Journal:  AIDS       Date:  2010-08-24       Impact factor: 4.177

2.  Susceptibility of in vitro stimulated PBMC to infection with NSI HIV-1 is associated with levels of CCR5 expression and beta-chemokine production.

Authors:  H Blaak; L J Ran; R Rientsma; H Schuitemaker
Journal:  Virology       Date:  2000-02-15       Impact factor: 3.616

3.  Interleukin-2 up-regulates expression of the human immunodeficiency virus fusion coreceptor CCR5 by CD4+ lymphocytes in vivo.

Authors:  D Weissman; M Dybul; M B Daucher; R T Davey; R E Walker; J A Kovacs
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

4.  CD4 T cell depletion at the cervix during HIV infection is associated with accumulation of terminally differentiated T cells.

Authors:  P P Gumbi; S Z Jaumdally; A L Salkinder; W A Burgers; N N Mkhize; W Hanekom; D Coetzee; A Williamson; J S Passmore
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

5.  Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection.

Authors:  Fransje A Koning; Sigrid A Otto; Mette D Hazenberg; Linda Dekker; Maria Prins; Frank Miedema; Hanneke Schuitemaker
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

6.  Human immunodeficiency virus (HIV) gag antigen-specific T-helper and granule-dependent CD8 T-cell activities in exposed but uninfected heterosexual partners of HIV type 1-infected individuals in North India.

Authors:  Suresh Pallikkuth; Ajay Wanchu; Archana Bhatnagar; Ravinder Kaur Sachdeva; Meera Sharma
Journal:  Clin Vaccine Immunol       Date:  2007-09

7.  Distinct patterns of peripheral HIV-1-specific interferon- gamma responses in exposed HIV-1-seronegative individuals.

Authors:  Anthony Kebba; Pontiano Kaleebu; Samantha Rowland; Rebecca Ingram; Jimmy Whitworth; Nesrina Imami; Frances Gotch
Journal:  J Infect Dis       Date:  2004-04-19       Impact factor: 5.226

8.  Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons.

Authors:  N F Bernard; C M Yannakis; J S Lee; C M Tsoukas
Journal:  J Infect Dis       Date:  1999-03       Impact factor: 5.226

9.  Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure.

Authors:  W A Paxton; S R Martin; D Tse; T R O'Brien; J Skurnick; N L VanDevanter; N Padian; J F Braun; D P Kotler; S M Wolinsky; R A Koup
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

10.  Association of chemokine receptor gene (CCR2-CCR5) haplotypes with acquisition and control of HIV-1 infection in Zambians.

Authors:  Rakhi Malhotra; Liangyuan Hu; Wei Song; Ilene Brill; Joseph Mulenga; Susan Allen; Eric Hunter; Sadeep Shrestha; Jianming Tang; Richard A Kaslow
Journal:  Retrovirology       Date:  2011-03-23       Impact factor: 4.602

View more
  7 in total

Review 1.  Human Genetic Variation and HIV/AIDS in Papua New Guinea: Time to Connect the Dots.

Authors:  Rajeev K Mehlotra
Journal:  Curr HIV/AIDS Rep       Date:  2018-12       Impact factor: 5.071

2.  S100A14 Is Increased in Activated NK Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte-NK Crosstalk.

Authors:  Krystal Colón; David W Speicher; Peter Smith; Mack Taylor; David S Metzger; Luis J Montaner; Costin Tomescu
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

3.  Low level expression of the Mitochondrial Antiviral Signaling protein (MAVS) associated with long-term nonprogression in SIV-infected rhesus macaques.

Authors:  Miaomiao Zhang; Zhuotao Fu; Jiantao Chen; Boqiang Zhu; Ye Cheng; Linchun Fu
Journal:  Virol J       Date:  2018-10-16       Impact factor: 4.099

4.  Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.

Authors:  Smritee Dabee; Shaun L Barnabas; Katie S Lennard; Shameem Z Jaumdally; Hoyam Gamieldien; Christina Balle; Anna-Ursula Happel; Brandon D Murugan; Anna-Lise Williamson; Nonhlanhla Mkhize; Janan Dietrich; David A Lewis; Francesca Chiodi; Thomas J Hope; Robin Shattock; Glenda Gray; Linda-Gail Bekker; Heather B Jaspan; Jo-Ann S Passmore
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

Review 5.  Interferon-Gamma-Mediated Osteoimmunology.

Authors:  Mengjia Tang; Li Tian; Guojing Luo; Xijie Yu
Journal:  Front Immunol       Date:  2018-06-29       Impact factor: 7.561

Review 6.  Metabolomics as an Approach to Characterise the Contrasting Roles of CCR5 in the Presence and Absence of Disease.

Authors:  Anandi Rautenbach; Aurelia A Williams
Journal:  Int J Mol Sci       Date:  2020-02-21       Impact factor: 5.923

7.  Enhanced Signaling Through the TLR9 Pathway Is Associated With Resistance to HIV-1 Infection in Chinese HIV-1-Exposed Seronegative Individuals.

Authors:  Junjun Jiang; Xi Hu; Wenwei Li; Jie Liu; Bingyu Liang; Hui Chen; Jiegang Huang; Ning Zang; Chuanyi Ning; Yanyan Liao; Rongfeng Chen; Jingzhen Lai; Jiemei Chu; Peijiang Pan; Ping Cui; Qiao Tang; Xiu Chen; Hao Liang; Li Ye
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.